Filing Details

Accession Number:
0001250853-21-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-18 16:35:27
Reporting Period:
2021-03-17
Accepted Time:
2021-03-18 16:35:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561743 Kindred Biosciences Inc. KIN Pharmaceutical Preparations (2834) 461160142
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593865 Denise Bevers C/o Kindred Biosciences, Inc.
1555 Bayshore Highway, Suite 200
Burlingame CA 94010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-17 8,396 $0.32 8,396 No 4 M Indirect By SD Scientific, Inc.
Common Stock Disposition 2021-03-17 8,396 $5.00 0 No 4 S Indirect By SD Scientific, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By SD Scientific, Inc.
No 4 S Indirect By SD Scientific, Inc.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-17 8,396 $0.00 8,396 $0.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-05-09 2023-05-09 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 143,835 Direct
Footnotes
  1. Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.015, inclusive. The Reporting Person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.